"10.1371_journal.pone.0062070","plos one","2013-05-17T00:00:00Z","Elton Rexhepaj; Margr√©t Agnarsd√≥ttir; Julia Bergman; Per-Henrik Edqvist; Michael Bergqvist; Mathias Uhl√©n; William M Gallagher; Emma Lundberg; Fredrik Ponten","Department of Genetics and Pathology and Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; Section of Oncology, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, KTH ‚Ä Royal Institute of Technology, Stockholm, Sweden; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, Dublin, Ireland; OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin, Ireland","Conceived and designed the experiments: ER FP MA. Performed the experiments: JB PHE. Analyzed the data: ER FP. Contributed reagents/materials/analysis tools: EL MU MB WG. Wrote the paper: ER FP.","Prof. William Gallagher is co-founder and Chief Scientific Officer within OncoMark Limited. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. The other authors have no financial or other interests with regard to the pre-submitted abstract that might be construed as conflict of interest.","2013","05","Elton Rexhepaj","ER",9,TRUE,3,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
